Literature DB >> 19457584

Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach.

Jesús Rodríguez-Baño1, Lola García, Encarnación Ramírez, Luis Martínez-Martínez, Miguel A Muniain, Felipe Fernández-Cuenca, Margarita Beltrán, Juan Gálvez, Jose M Rodríguez, Carmen Velasco, Concepción Morillo, Federico Perez, Andrea Endimiani, Robert A Bonomo, Alvaro Pascual.   

Abstract

BACKGROUND: Acinetobacter baumannii (Ab) is emerging as a multidrug-resistant (MDR) nosocomial pathogen of considerable clinical importance. Data on the efficacy of infection control measures in endemic situations are lacking. Here, we investigated the impact of a long-term multifaceted "bundle" approach in controlling endemic MDR Ab in a 950-bed tertiary care center.
METHODS: Ongoing staff education, promotion of hand hygiene, strict Contact and Isolation Precautions, environmental cleaning, and targeted active surveillance in high-risk areas during periods of likely transmission and contamination were initiated in this program. To assess the efficacy of our interventions, we recorded (before and after the intervention) the epidemiologic and clinical features of MDR Ab infections and determined the clonal relationship among MDR Ab bloodstream isolates by pulsed-field gel electrophoresis.
RESULTS: Before the "bundle" was instituted, the rate of colonization/infection was 0.82 cases per 100 admissions (1994-1995). Colonization/infection rates showed a sustained decrease after implementation of the control program in 1995 to 0.46 in 1996-1997 and to 0.21 in 1998-2003 (P < .001). Coincident with the institution of this program, the rate of bacteremia because of MDR Ab decreased 6-fold during the 8-year observation period. A notable change in the clonal distribution of the MDR Ab isolates was also demonstrated.
CONCLUSION: The implementation of a comprehensive and multifaceted infection control program ("bundle") in a tertiary care center effectively controlled the spread and clinical impact of MDR Ab.

Entities:  

Mesh:

Year:  2009        PMID: 19457584      PMCID: PMC2783564          DOI: 10.1016/j.ajic.2009.01.008

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  34 in total

1.  Prevalence of nosocomial infections in Spain: EPINE study 1990-1997. EPINE Working Group.

Authors:  J Vaqué; J Rosselló; J L Arribas
Journal:  J Hosp Infect       Date:  1999-12       Impact factor: 3.926

2.  The use and interpretation of quasi-experimental studies in infectious diseases.

Authors:  Anthony D Harris; Douglas D Bradham; Mona Baumgarten; Ilene H Zuckerman; Jeffrey C Fink; Eli N Perencevich
Journal:  Clin Infect Dis       Date:  2004-05-12       Impact factor: 9.079

3.  Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients.

Authors:  J L García-Garmendia; C Ortiz-Leyba; J Garnacho-Montero; F J Jiménez-Jiménez; J Monterrubio-Villar; M Gili-Miner
Journal:  Crit Care Med       Date:  1999-09       Impact factor: 7.598

4.  Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii.

Authors:  B Mulin; D Talon; J F Viel; C Vincent; R Leprat; M Thouverez; Y Michel-Briand
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-07       Impact factor: 3.267

5.  An outbreak of Acinetobacter baumannii: the importance of cross-transmission.

Authors:  E M D'Agata; V Thayer; W Schaffner
Journal:  Infect Control Hosp Epidemiol       Date:  2000-09       Impact factor: 3.254

6.  Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).

Authors:  Lynne Sehulster; Raymond Y W Chinn
Journal:  MMWR Recomm Rep       Date:  2003-06-06

Review 7.  Acinetobacter outbreaks, 1977-2000.

Authors:  Maria Virginia Villegas; Alan I Hartstein
Journal:  Infect Control Hosp Epidemiol       Date:  2003-04       Impact factor: 3.254

8.  Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned.

Authors:  David Landman; John M Quale; David Mayorga; Adedeyo Adedeji; Kalyani Vangala; Jayshree Ravishankar; Carlos Flores; Steven Brooks
Journal:  Arch Intern Med       Date:  2002-07-08

9.  Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology.

Authors:  D Villers; E Espaze; M Coste-Burel; F Giauffret; E Ninin; F Nicolas; H Richet
Journal:  Ann Intern Med       Date:  1998-08-01       Impact factor: 25.391

10.  Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital.

Authors:  M Ayan; R Durmaz; E Aktas; B Durmaz
Journal:  J Hosp Infect       Date:  2003-05       Impact factor: 3.926

View more
  27 in total

1.  Quantitative real-time PCR for detection of Acinetobacter baumannii colonization in the hospital environment.

Authors:  Michael J McConnell; Ana Pérez-Ordóñez; Pilar Pérez-Romero; Raquel Valencia; José Antonio Lepe; Isabel Vázquez-Barba; Jerónimo Pachón
Journal:  J Clin Microbiol       Date:  2012-02-01       Impact factor: 5.948

2.  Positive predictive value of Leeds acinetobacter medium for environmental surveillance of Acinetobacter baumannii.

Authors:  Michael J McConnell; Pilar Pérez-Romero; José Antonio Lepe; Ana Pérez-Ordóñez; Raquel Valencia; Isabel Vázquez-Barba; Jerónimo Pachón
Journal:  J Clin Microbiol       Date:  2011-09-28       Impact factor: 5.948

3.  Longitudinal epidemiology of multidrug-resistant (MDR) Acinetobacter species in a tertiary care hospital.

Authors:  Ji Hoon Baang; Peter Axelrod; Brooke K Decker; Andrea M Hujer; Georgia Dash; Allan R Truant; Robert A Bonomo; Thomas Fekete
Journal:  Am J Infect Control       Date:  2011-08-11       Impact factor: 2.918

4.  Use of vaporized hydrogen peroxide decontamination during an outbreak of multidrug-resistant Acinetobacter baumannii infection at a long-term acute care hospital.

Authors:  Amy Ray; Federico Perez; Amanda M Beltramini; Marta Jakubowycz; Patricia Dimick; Michael R Jacobs; Kathy Roman; Robert A Bonomo; Robert A Salata
Journal:  Infect Control Hosp Epidemiol       Date:  2010-10-25       Impact factor: 3.254

Review 5.  Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit.

Authors:  Marin H Kollef; Yoav Golan; Scott T Micek; Andrew F Shorr; Marcos I Restrepo
Journal:  Clin Infect Dis       Date:  2011-09       Impact factor: 9.079

6.  Traumatic injury, early gene expression, and gram-negative bacteremia.

Authors:  Callie M Thompson; Chin H Park; Ronald V Maier; Grant E O'Keefe
Journal:  Crit Care Med       Date:  2014-06       Impact factor: 7.598

7.  Acinetobacter baumannii isolates from pets and horses in Switzerland: molecular characterization and clinical data.

Authors:  Andrea Endimiani; Kristine M Hujer; Andrea M Hujer; Isabelle Bertschy; Alexandra Rossano; Christoph Koch; Vinzenz Gerber; Thierry Francey; Robert A Bonomo; Vincent Perreten
Journal:  J Antimicrob Chemother       Date:  2011-07-06       Impact factor: 5.790

8.  Task force on management and prevention of Acinetobacter baumannii infections in the ICU.

Authors:  José Garnacho-Montero; George Dimopoulos; Garyphallia Poulakou; Murat Akova; José Miguel Cisneros; Jan De Waele; Nicola Petrosillo; Harald Seifert; Jean François Timsit; Jordi Vila; Jean-Ralph Zahar; Matteo Bassetti
Journal:  Intensive Care Med       Date:  2015-10-05       Impact factor: 17.440

9.  Risk Factors and Outcomes Associated with Multidrug-Resistant Acinetobacter baumannii upon Intensive Care Unit Admission.

Authors:  Natalia Blanco; Anthony D Harris; Clare Rock; J Kristie Johnson; Lisa Pineles; Robert A Bonomo; Arjun Srinivasan; Melinda M Pettigrew; Kerri A Thom
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

10.  Economic value of Acinetobacter baumannii screening in the intensive care unit.

Authors:  B Y Lee; S M McGlone; Y Doi; R R Bailey; L H Harrison
Journal:  Clin Microbiol Infect       Date:  2011-04-04       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.